Trailing-twelve-month (TTM) revenue is $3.79 Billion with a year-over-year growth of +3.73%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-28 | $951,286,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q3 FY2026Period ended 2025-12-28 | $919,126,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q4 FY2026Period ended 2026-03-31 | $987,940,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-20 |
| Q1 FY2027Period ended 2026-07-05 | $935,641,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12 |
| TTM revenue | $3,793,993,000 |
Current P/S: $6,510,334,981 market capitalization ÷ $3,793,993,000 TTM revenue = 1.72x.
Market capitalization source: FMP quote. Quote observed 2026-09-21T20:00:02.000Z. Latest revenue period ended 2026-07-05.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-07-05): $935.64M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-22T00:15:52.148Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2020-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Product | N/A | N/A | $3.3B | $3.2B | $3.3B | $3.4B |
| Service | $296M | $353M | $401M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20152015-03-31 · USD | FY20162016-03-31 · USD | FY20172017-03-31 · USD | FY20182018-03-31 · USD | FY20192019-03-31 · USD | FY20202020-03-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $30M | $33M | $26M | $30M | $29M | $46M |
| Asia | $34M | $24M | $23M | $23M |
$3.79B
$3.79 Billion
+3.73%
vs. $3.66B a year ago (TTM)
+4.20%
5 Year compound annual growth rate
1 Year
+3.73%
3 Year
+0.67%
5 Year
+4.20%
10 Year
+4.88%
15 Year
+4.02%
20 Year
+5.35%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $3.75B | +$133.80M | +3.70% |
| 2025 | $3.62B | +$35.71M | +1.00% |
| 2024 | $3.58B | ($126.71M) | (3.42%) |
| 2023 | $3.71B | +$351.26M | +10.46% |
| 2022 | $3.36B | +$379.39M | +12.74% |
| 2021 |
TTM Growth
+3.73%
3-Year CAGR
+0.67%
5-Year CAGR
+4.20%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-22T00:15:52.148Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $361M |
| $371M |
| $21M |
| EMEA | $69M | $79M | $93M | $133M | $123M | $149M |
|---|
| $2.98B |
| ($109.94M) |
| (3.56%) |
| 2020 | $3.09B | +$279.87M | +9.97% |
| 2019 | $2.81B | +$226.20M | +8.76% |
| 2018 | $2.58B | +$214.70M | +9.07% |
| 2017 | $2.37B | +$50.90M | +2.20% |
